Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other financing activities: 2021-2024

Historic Other financing activities for Immuneering (IMRX) over the last 4 years, with Dec 2024 value amounting to $40,988.

  • Immuneering's Other financing activities was N/A to $40,988 in Q4 2024 from the same period last year, while for Dec 2024 it was $538,382, marking a year-over-year change of. This contributed to the annual value of $40,988 for FY2024, which is 79.88% down from last year.
  • Latest data reveals that Immuneering reported Other financing activities of $40,988 as of FY2024, which was down 79.88% from $203,768 recorded in FY2023.
  • In the past 5 years, Immuneering's Other financing activities ranged from a high of $2.1 million in FY2021 and a low of $40,988 during FY2024.
  • Moreover, its 3-year median value for Other financing activities was $203,768 (2023), whereas its average is $175,377.
  • Data for Immuneering's Other financing activities shows a maximum YoY slumped of 86.75% (in 2022) over the last 5 years.
  • Over the past 4 years, Immuneering's Other financing activities (Yearly) stood at $2.1 million in 2021, then slumped by 86.75% to $281,375 in 2022, then fell by 27.58% to $203,768 in 2023, then tumbled by 79.88% to $40,988 in 2024.